Get started
Author

Eva Maria Wagner

Observed names: E M Wagner, E. Wagner, Elizabeth Wagner, Eva M Wagner, Eva M. Wagner, Eva Wagner, Wagner, E. M., Wagner, Eva
Observed institutions: University of Minnesota, Mayo Clinic, Emory University, University of Freiburg, University of Mannheim, Johannes Gutenberg University Mainz, University Medical Center Freiburg, Deutsche Klinik für Diagnostik, University Medical Center of the Johannes Gutenberg University Mainz, University Hospital Schleswig-Holstein, Jena University Hospital, University Medical Centre Mannheim, Medizinische Fakultät Mannheim, Leipzig University
ORCID: 0009-0001-8521-7967
Observed ORCID: 0009-0001-8521-7967
OpenAlex ID: A5113800331
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
2020 · Robert Zeiser, Nikolas von Bubnoff, et al. · New England Journal of Medicine · 882
PDF
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
2024 · Mark J. Levis, Mehdi Hamadani, et al. · Journal of Clinical Oncology · 225
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation
2018 · Mareike Frick, Willy Chan, et al. · Journal of Clinical Oncology · 223
Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
2002 · Torsten E Reichert, Laura Strauss, et al. · PubMed · 212
Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
2014 · Celalettin Ustun, Andreas Reiter, et al. · Journal of Clinical Oncology · 191
PDF
Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
1998 · T E Reichert, R Day, et al. · PubMed · 147
Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage
2026 · Tug, Suzan, Helmig, Susanne, et al. · PubMed · 87
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
2010 · Jürgen Kuball, Karin de Boer, et al. · Cancer Immunology Immunotherapy · 74
PDF
Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation
2016 · Daniel Fuerst, Christine Neuchel, et al. · Blood · 51
PDF
Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation
2008 · Eva Distler, Elke Schnürer, et al. · Transplantation and Cellular Therapy · 28
PDF
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors—A Retrospective Study
2017 · Christine Neuchel, Daniel Fürst, et al. · PLoS ONE · 26
PDF
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients
2017 · Chrysanthi Tsamadou, Daniel Fürst, et al. · Haematologica · 22
PDF
Human Epidermal Langerhans Cells Replenish Skin Xenografts and Are Depleted by Alloreactive T Cells In Vivo
2011 · Julia Hemmerling, Joanna Wegner-Kops, et al. · The Journal of Immunology · 19
PDF
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation
2009 · R G Meyer, E M Wagner, et al. · Bone Marrow Transplantation · 15
Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease
2021 · Joanna Wegner, Beate Weidenthaler‐Barth, et al. · Experimental Dermatology · 8
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation
2017 · Daniel Fürst, Dietger Niederwieser, et al. · Haematologica · 5
PDF
Conversion from MRD Positive to Negative Status in AML Patients in CR1 after Treatment with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine
2020 · Arjan van de Loosdrecht, Janine van Elssen, et al. · Blood · 4
Treatment with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in AML Patients Shows MRD Conversion and Improved Survival
2021 · Arjan A. Van de Loosdrecht, Jacqueline Cloos, et al. · Blood · 3
Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia
2021 · Christina Rautenberg, Friedrich Stölzel, et al. · Blood · 3
Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,
2011 · Eva M Wagner, Daniela Wehler, et al. · Blood · 3
Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.
2006 · Eva M. Wagner, Juergen Kuball, et al. · Blood · 2
Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation
2022 · Alexandros Spyridonidis, Myriam Labopin, et al. · Blood · 1
Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party
2022 · Jesus Duque Afonso, Jürgen Finke, et al. · Blood · 1
Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Multicenter Phase IIa Study
2019 · Francis Ayuketang Ayuk, Eva Maria Wagner, et al. · Blood · 1
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
2015 · Daniel Fürst, Christine Zollikofer, et al. · Transplantation and Cellular Therapy · 1
PDF
Works count: 49
Citation count: 2,236
H-index: 14
I10-index: 14
Year
Topic
Type